<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37341437</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>22</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>01</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2324-7096</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><PubDate><Year>2023</Year><Season>Jan-Dec</Season></PubDate></JournalIssue><Title>Journal of investigative medicine high impact case reports</Title><ISOAbbreviation>J Investig Med High Impact Case Rep</ISOAbbreviation></Journal><ArticleTitle>Rare Coexistence of Acute Intermittent Porphyria With Systemic Lupus Erythematous: Case Report and Literature Review.</ArticleTitle><Pagination><StartPage>23247096231181856</StartPage><MedlinePgn>23247096231181856</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">23247096231181856</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1177/23247096231181856</ELocationID><Abstract><AbstractText>Porphyrias, particularly acute intermittent porphyria (AIP), are rare, inherited disorders of heme synthesis. On the other hand, systemic lupus erythematosus (SLE) is an uncommon autoimmune disease that affects women predominantly. The coexistence of AIP and SLE is rare. We report a case of concomitant diagnosis of AIP and SLE in a 21-year-old woman who presented with recurrent acute abdominal, chest, and back pain associated with nausea and vomiting, followed by arthralgia, multiple joint pain, and rash. Investigations revealed severe hyponatremia related to SIADH (syndrome of inappropriate antidiuretic hormone secretion) with a positive SLE antibody panel and a positive urine screen for porphobilinogen. Molecular test confirmed the diagnosis of AIP with a pathogenic mutation in the <i>HMBS</i> gene.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yusuf</LastName><ForeName>Asmaa</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Tawam Hospital, Al Ain, UAE.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alhaj</LastName><ForeName>Omar</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Tawam Hospital, Al Ain, UAE.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aldaheri</LastName><ForeName>Afra</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Internal Medicine, Tawam Hospital, Al Ain, UAE.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>AlShamsi</LastName><ForeName>Aisha</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Genetics and Metabolic, Department of Paediatrics, Tawam Hospital, Al Ain, UAE.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>AlMarshoodi</LastName><ForeName>Mozah</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Hematology &amp; Oncology, Tawam Hospital, Al Ain, UAE.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>AlKindi</LastName><ForeName>Fatima</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-7781-9968</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, Tawam Hospital, Al Ain, UAE.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mohammed</LastName><ForeName>Farooqi</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Tawam Hospital, Al Ain, UAE.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Almazrouei</LastName><ForeName>Raya</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0003-0878-1123</Identifier><AffiliationInfo><Affiliation>Division of Endocrinology, Department of Internal Medicine, Tawam Hospital, Al Ain, UAE.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, UAE.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Investig Med High Impact Case Rep</MedlineTA><NlmUniqueID>101624758</NlmUniqueID><ISSNLinking>2324-7096</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017118" MajorTopicYN="Y">Porphyria, Acute Intermittent</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005076" MajorTopicYN="Y">Exanthema</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009325" MajorTopicYN="N">Nausea</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007010" MajorTopicYN="Y">Hyponatremia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D035583" MajorTopicYN="N">Rare Diseases</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SIADH</Keyword><Keyword MajorTopicYN="N">SLE</Keyword><Keyword MajorTopicYN="N">acute intermittent porphyria</Keyword><Keyword MajorTopicYN="N">acute porphyria</Keyword></KeywordList><CoiStatement>The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>22</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>21</Day><Hour>13</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>21</Day><Hour>8</Hour><Minute>23</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37341437</ArticleId><ArticleId IdType="pmc">PMC10288411</ArticleId><ArticleId IdType="doi">10.1177/23247096231181856</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bissell DM, Anderson KE, Bonkovsky HL.Porphyria. N Engl J Med. 2017;377(9):862-872.</Citation><ArticleIdList><ArticleId IdType="pubmed">28854095</ArticleId></ArticleIdList></Reference><Reference><Citation>Fanouriakis A, Tziolos N, Bertsias G, Boumpas DT.Update &#x3bf;n the diagnosis and management of systemic lupus erythematosus. Ann Rheum Dis. 2021;80(1):14-25.</Citation><ArticleIdList><ArticleId IdType="pubmed">33051219</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrade TMDS, Effting ACM, L&#xfc;ckmann LF, et al.. Systemic lupus erythematosus overlaid acute intermittent porphyria. In: Blucher Medical Proceedings. Editora Blucher; 2019:270-270. Accessed April 12, 2023. http://www.proceedings.blucher.com.br/article-details/32762</Citation></Reference><Reference><Citation>Esteve-Valverde E, Tapiz-Reula A, Ruiz D, Alijotas-Reig J.Systemic lupus erythematosus and hydroxychloroquine-related acute intermittent porphyria. Rheumatol Int. 2020;40(5):777-783.</Citation><ArticleIdList><ArticleId IdType="pubmed">31865445</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu A, Zhou L, Zhu H, Li Y, Yang J.Systemic lupus erythematosus and hereditary coproporphyria: two different entities diagnosed by WES in the same patient. Biomed Res Int. 2022;2022:9096999.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9167117</ArticleId><ArticleId IdType="pubmed">35669728</ArticleId></ArticleIdList></Reference><Reference><Citation>Al Dhanhani AM, Agarwal M, Othman YS, Bakoush O.Incidence and prevalence of systemic lupus erythematosus among the native Arab population in UAE. Lupus. 2017;26(6):664-669.</Citation><ArticleIdList><ArticleId IdType="pubmed">27831539</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang B, Rudnick S, Cengia B, Bonkovsky HL.Acute hepatic porphyrias: review and recent progress. Hepatol Commun. 2019;3(2):193-206.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6357830</ArticleId><ArticleId IdType="pubmed">30766957</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen B, Solis-Villa C, Hakenberg J, et al.. Acute intermittent porphyria: predicted pathogenicity of HMBS variants indicates extremely low penetrance of the autosomal dominant disease. Hum Mutat. 2016;37(11):1215-1222.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5063710</ArticleId><ArticleId IdType="pubmed">27539938</ArticleId></ArticleIdList></Reference><Reference><Citation>Nordmann Y, Puy H, Da Silva V, et al.. Acute intermittent porphyria: prevalence of mutations in the porphobilinogen deaminase gene in blood donors in France. J Intern Med. 1997;242(3):213-217.</Citation><ArticleIdList><ArticleId IdType="pubmed">9350165</ArticleId></ArticleIdList></Reference><Reference><Citation>Baumann K, Kauppinen R.Penetrance and predictive value of genetic screening in acute porphyria. Mol Genet Metab. 2020;130(1):87-99.</Citation><ArticleIdList><ArticleId IdType="pubmed">32067921</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersson C, Floderus Y, Wikberg A, Lithner F.The W198X and R173W mutations in the porphobilinogen deaminase gene in acute intermittent porphyria have higher clinical penetrance than R167W. A population-based study. Scand J Clin Lab Invest. 2000;60(7):643-648.</Citation><ArticleIdList><ArticleId IdType="pubmed">11202057</ArticleId></ArticleIdList></Reference><Reference><Citation>To-Figueras J, Badenas C, Carrera C, et al.. Genetic and biochemical characterization of 16 acute intermittent porphyria cases with a high prevalence of the R173W mutation. J Inherit Metab Dis. 2006;29(4):580-585.</Citation><ArticleIdList><ArticleId IdType="pubmed">16817012</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolfram S.[Colic caused by porphyrin; symptomatology of the acute erythematodes]. Hautarzt. 1952;3(7):298-300.</Citation><ArticleIdList><ArticleId IdType="pubmed">12980476</ArticleId></ArticleIdList></Reference><Reference><Citation>Marsden CW.Porphyria during chloroquine therapy. Br J Dermatol. 1959;71(6):219-222.</Citation><ArticleIdList><ArticleId IdType="pubmed">13662522</ArticleId></ArticleIdList></Reference><Reference><Citation>Passaron HN, Lloveras JH, Vazquez E.[Exacerbated chronic lupus erythematosus and acute porphyria]. Arch Argent Dermatol. 1962;12:299-303.</Citation><ArticleIdList><ArticleId IdType="pubmed">13941709</ArticleId></ArticleIdList></Reference><Reference><Citation>Filiotou A, Vaiopoulos G, Capsimali V, Stavrianeas N, Kaloterakis A.Acute intermittent porphyria and systemic lupus erythematosus: report of a case and review of the literature. Lupus. 2002;11(3):190-192.</Citation><ArticleIdList><ArticleId IdType="pubmed">11999885</ArticleId></ArticleIdList></Reference><Reference><Citation>Quilichini R, Guerder A.[Systemic lupus erythematosus and acute intermittent porphyria]. Nouv Presse Med. 1973;2(16):1074.</Citation><ArticleIdList><ArticleId IdType="pubmed">4706658</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosemarin JI, Nigro EJ, Levere RD, et al.. Systemic lupus erythematosus and acute intermittent porphyria: coincidence or association. Arthritis Rheum. 1982;25(9):1134-1137.</Citation><ArticleIdList><ArticleId IdType="pubmed">7126298</ArticleId></ArticleIdList></Reference><Reference><Citation>Allard SA, Scott JT.Systemic lupus erythematosus and acute intermittent porphyria. Br J Rheumatol. 1989;28(3):254-256.</Citation><ArticleIdList><ArticleId IdType="pubmed">2730987</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersson C, Lithner F.Hypertension and renal disease in patients with acute intermittent porphyria. J Intern Med. 1994;236(2):169-175.</Citation><ArticleIdList><ArticleId IdType="pubmed">8046316</ArticleId></ArticleIdList></Reference><Reference><Citation>Alioua C, Patel A, Bakir AA.Co-existence of systemic lupus erythematosus and severe hepatic porphyria. Nephrol Dial Transplant. 1999;14(12):2944-2946.</Citation><ArticleIdList><ArticleId IdType="pubmed">10570103</ArticleId></ArticleIdList></Reference><Reference><Citation>Korkmaz C.Delayed diagnosis of porphyria based on manifestations of systemic lupus erythematosus and ankylosing spondylitis. J Nephrol. 2006;19(4):535-539.</Citation><ArticleIdList><ArticleId IdType="pubmed">17048215</ArticleId></ArticleIdList></Reference><Reference><Citation>Bharati A, Kleyn E, Wong GA, Leonard N, King CM.A spectrum of lupus erythematosus from verrucous to systemic, coexisting with two types of porphyria. J Eur Acad Dermatol Venereol. 2007;21(7):1009-1010.</Citation><ArticleIdList><ArticleId IdType="pubmed">17659034</ArticleId></ArticleIdList></Reference><Reference><Citation>Patil AD, Karnik ND, Nadkar MY, Gupta VA, Muralidhara K, Passidhi S.Guillain Barr&#xe9; syndrome, systemic lupus erythematosus and acute intermittent porphyria&#x2014;a deadly trio. J Assoc Physicians India. 2015;63(11):60-63.</Citation><ArticleIdList><ArticleId IdType="pubmed">29900713</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris MY.Coexistent systemic lupus erythematosus and porphyria. Arch Intern Med. 1966;117(3):425.</Citation></Reference><Reference><Citation>Vittori F, Desaegher JL.Lupus erythemateux dissemine et porphyrie aigue intermittente. Association ou Coincidence. Sem Hop. 1977;53:1542-1548. Accessed June 5, 2023. http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=PASCAL7850087388</Citation><ArticleIdList><ArticleId IdType="pubmed">197647</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonkovsky HL, Maddukuri VC, Yazici C, et al.. Acute porphyrias in the USA: features of 108 subjects from porphyrias consortium. Am J Med. 2014;127(12):1233-1241.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4563803</ArticleId><ArticleId IdType="pubmed">25016127</ArticleId></ArticleIdList></Reference><Reference><Citation>European Porphyria Network. EPNET, the European Porphyria Network. Date unknown. Accessed April 12, 2023. https://porphyria.eu/</Citation></Reference><Reference><Citation>Chang C, Gershwin ME.Drug-induced lupus erythematosus: incidence, management and prevention. Drug Saf. 2011;34(5):357-374.</Citation><ArticleIdList><ArticleId IdType="pubmed">21513360</ArticleId></ArticleIdList></Reference><Reference><Citation>Costedoat-Chalumeau N, Dunogu&#xe9; B, Morel N, Le Guern V, Guettrot-Imbert G.Hydroxychloroquine: a multifaceted treatment in lupus. Presse Med. 2014;43(6, pt 2):e167-e180.</Citation><ArticleIdList><ArticleId IdType="pubmed">24855048</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubin RL.Drug-induced lupus. Expert Opin Drug Saf. 2015;14(3):361-378.</Citation><ArticleIdList><ArticleId IdType="pubmed">25554102</ArticleId></ArticleIdList></Reference><Reference><Citation>Arora S, Young S, Kodali S, Singal AK.Hepatic porphyria: a narrative review. Indian J Gastroenterol. 2016;35(6):405-418.</Citation><ArticleIdList><ArticleId IdType="pubmed">27796941</ArticleId></ArticleIdList></Reference><Reference><Citation>Pischik E, Kauppinen R.An update of clinical management of acute intermittent porphyria. Appl Clin Genet. 2015;8:201-214.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4562648</ArticleId><ArticleId IdType="pubmed">26366103</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>